dermatologic toxicities from monoclonal antibodies and tyrosine kinase inhibitors against egfr pathophysiology and management皮肤毒性对egfr单克隆抗体、酪氨酸激酶抑制剂病理生理学和管理.pdfVIP

Hindawi Publishing Corporation Chemotherapy Research and Practice Volume 2012, Article ID 351210, 10 pages doi:10.1155/2012/351210 Review Article Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management Shaad E. Abdullah, Missak Haigentz Jr., and Bilal Piperdi Division of Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New york, NY 10461, USA Correspondence should be addressed to Bilal Piperdi, bpiperdi@montefi